The Effect of Breast Cancer Resistance Protein and P-Glycoprotein on the Brain Penetration of Flavopiridol, Imatinib Mesylate (Gleevec), Prazosin, and 2-Methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic Acid (PF-407288) in Mice

2009 ◽  
Vol 37 (5) ◽  
pp. 946-955 ◽  
Author(s):  
Lin Zhou ◽  
Kari Schmidt ◽  
Frederick R. Nelson ◽  
Veronica Zelesky ◽  
Matthew D. Troutman ◽  
...  
2015 ◽  
Vol 33 (5) ◽  
pp. 1012-1019 ◽  
Author(s):  
Mark C. de Gooijer ◽  
Ping Zhang ◽  
Nishita Thota ◽  
Isabel Mayayo-Peralta ◽  
Levi C. M. Buil ◽  
...  

2009 ◽  
Vol 29 (6) ◽  
pp. 1079-1083 ◽  
Author(s):  
Leon M Tai ◽  
A Jane Loughlin ◽  
David K Male ◽  
Ignacio A Romero

The clearance of amyloid beta (Aβ) from the brain represents a novel therapeutic target for Alzheimer's disease. Conflicting data exist regarding the contribution of adenosine triphosphatebinding cassette transporters to the clearance of Aβ through the blood-brain barrier. Therefore, we investigated whether Aβ could be a substrate for P-glycoprotein (P-gp) and/or for breast cancer resistance protein (BCRP) using a human brain endothelial cell line, hCMEC/D3. Inhibition of P-gp and BCRP increased apical-to-basolateral, but not basolateral-to-apical, permeability of hCMEC/D3 cells to 125l Aβ 1–40. Our in vitro data suggest that P-gp and BCRP might act to prevent the blood-borne Aβ 1–40 from entering the brain.


Sign in / Sign up

Export Citation Format

Share Document